Gujrathi Sheila 4
4 · Janux Therapeutics, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
GUJRATHI SHEILA
Director
Transactions
- Other
Common Stock
2024-02-29+2,986→ 108,028 total
Footnotes (1)
- [F1]Represents receipt of securities in a pro rata, in-kind distribution, and not a purchase of securities, by ABV SPV I GP LLC, of which Reporting Person is a member.